Fang Z, Liu Y-W, Shi Y-K, Yu X-B, Huang W-Q, Ji X
Department of Parasitology, Nantong Medical College, Nantong, Jiangsu, 226001, China.
Ann Trop Med Parasitol. 2002 Jul;96(5):463-8. doi: 10.1179/000349802125001258.
The humoral responses elicited in mice by inoculation, in various doses and by several routes, with plasmid DNA containing the gene coding for the circumsporozoite protein (CSP) of Plasmodium falciparum FCC1/HN were compared with those evoked by inoculation with a recombinant expressed protein based on the CSP. With the DNA vaccine, intramuscular inoculations appeared the most effective, followed by intravenous and then subcutaneous injections, the responses in each case being dose-dependent. In both standard ELISA and dot-ELISA, sera from the mice immunized with the DNA were found to have much lower titres of antimalarial antibodies than the corresponding sera from mice immunized with the recombinant protein. Although both 'vaccines' elicited humoral immune responses in BALB/c mice, that based on plasmid DNA took much longer than the recombinant protein to induce high-titre antibody responses.
将含有恶性疟原虫FCC1/HN环子孢子蛋白(CSP)编码基因的质粒DNA以不同剂量、通过多种途径接种到小鼠体内所引发的体液免疫反应,与接种基于CSP的重组表达蛋白所引发的体液免疫反应进行了比较。对于DNA疫苗,肌肉内接种似乎最为有效,其次是静脉内接种,然后是皮下注射,每种情况下的反应均呈剂量依赖性。在标准ELISA和斑点ELISA中,发现用DNA免疫的小鼠血清中抗疟抗体滴度远低于用重组蛋白免疫的小鼠的相应血清。虽然两种“疫苗”均在BALB/c小鼠中引发了体液免疫反应,但基于质粒DNA的疫苗比重组蛋白诱导高滴度抗体反应所需的时间长得多。